Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed

Exclusion Criteria

• •Refusal to participate
• •Severe comorbid conditions making EGD hazardous for the patient, such as myocardial infarction \< 3 months with the exception if the myocardial infarction was caused by the UGIH, hemorrhagic or ischemic stroke \< 3 months, decompensated congestive heart failure, severe respiratory failure unless the patient is already intubated
• •Survival expected to be less than 72h as judged by treating clinician
• •Prisoners
• •Patient with severe mental illness precluding the ability to obtain informed consent
• •Ongoing anticoagulation which can not be reversed secondary to patient safety
• •Strongly suspected gastrointestinal perforation
• •Recent endoscopy (less than 30 days)